Indian IVD Market Dynamics Reviewed in New Netscribes Report Published at MarketPublishers.com

Share Article

New research report “In Vitro Diagnostics Market in India 2012” developed by Netscribes has been recently published by Market Publishers Ltd. The report finds that the market expansion could be challenged by faulty regulations leading to disorientation of IVD products and prevalence of laboratories without accreditation.

TD The Market Publishers, Ltd

http://marketpublishers.com/

Both domestic and foreign companies are eagerly entering the Indian in vitro diagnostics (IVD) business due to immense progress the industry has been witnessing in the past few years.

Among the major factors expected to drive the growth of the Indian IVD market one can name the increasing number of medical centers in the country along with high patient population growth rate, innovation by pharmaceutical companies, unhealthy lifestyle leading to chronic diseases, demand for cost effective, faster and sensitive results, increased affluence and healthcare awareness. However, the market expansion could be challenged by faulty regulations leading to disorientation of IVD products and prevalence of laboratories without accreditation.

New research report “In Vitro Diagnostics Market in India 2012” developed by Netscribes has been recently published by Market Publishers Ltd.

Report Details:

Title: In Vitro Diagnostics Market in India 2012
Published: September, 2012
Pages: 93
Price: US$ 795.00
http://marketpublishers.com/report/medicine_pharmaceuticals_biotechnology/healthcare_equipment_services/in-vitro-diagnostics-market-in-india-2012.html

The report provides true insights into the size and growth of the Indian in vitro diagnostics market and its different segments. It examines major market drivers, challenges and trends; discusses the laws and guidelines laid down by the regulatory bodies of the various countries drawing attention to the lack of regulations in India. The competitive landscape analysis is also included, accompanied by the profiles of the top market players along with their financial review, and Porter’s five forces analysis for the industry. Furthermore, the study is supplemented with strategic recommendations focusing on some effective strategic decisions companies can take up to increase their market shares.

Market segments covered include: immunochemistry, biochemistry, hematology, microbiology, blood gas & electrolyte, molecular diagnostics, urinalysis and coagulation analysis

Report Contents:

Slide 1: Executive Summary

Introduction

Slide 2: Uses of IVD Equipments
Slide 3: Segmentation of Product by Size of Equipment
Slide 4: Value Chain of IVD

Market Overview

Slide 5: In Vitro Diagnostics – Overview, Market Size and Growth (Value-Wise: 2011 – 2016e), Market Segmentation (Value-Wise: 2011)
Slide 6: In Vitro Diagnostics Instruments – Overview, Market Size and Growth (Value-Wise: 2011 – 2016e), In Vitro Diagnostics Reagents – Overview, Market Size and Growth (Value-Wise: 2011 – 2016e)
Slide 7: Immunochemistry – Overview, Market Size and Growth (Value-Wise: 2011 – 2016e), Market Segmentation (Value-Wise: 2011)
Slide 8: Immunochemistry Instruments– Overview, Market Size and Growth (Value-Wise: 2011 – 2016e), Immunochemistry Reagents – Overview, Market Size and Growth (Value-Wise: 2011 – 2016e)
Slide 9: Elisa Kits – Overview, Market Size and Growth (Value-Wise: 2011 – 2016e), Rapid Tests – Overview, Market Size and Growth (Value-Wise: 2011 – 2016e)
Slide 10: Biochemistry – Overview, Market Size and Growth (Value-Wise: 2011 – 2016e), Biochemistry Instruments Segmentation (Value-Wise: 2011)
Slide 11: Biochemistry Instruments – Overview, Market Size and Growth (Value-Wise: 2011 – 2016e), Biochemistry Reagents – Overview, Market Size and Growth (Value-Wise: 2011 – 2016e)
Slide 12: Hematology – Overview, Market Size and Growth (Value-Wise: 2011 – 2016e), Hematology Instruments Segmentation (Value-Wise: 2011)
Slide 13: Hematology Instruments – Overview, Market Size and Growth (Value-Wise: 2011 – 2016e), Hematology Reagents – Overview, Market Size and Growth (Value-Wise: 2011 – 2016e)
Slide 14: Hematology – Geographic Distribution (Value-Wise: 2011)
Slide 15: Microbiology – Overview, Market Size and Growth (Value-Wise: 2011 – 2016e), Market Segmentation (Value-Wise: 2011)
Slide 16: Microbiology Instruments – Overview, Market Size and Growth (Value-Wise: 2011 – 2016e), Microbiology Reagents – Overview, Market Size and Growth (Value-Wise: 2011 – 2016e)
Slide 17: Blood Gas & Electrolyte – Overview, Market Size and Growth (Value-Wise: 2011 – 2016e), Blood Gas & Electrolyte Instruments Segmentation (Value-Wise: 2011)
Slide 18: Blood Gas & Electrolyte Instruments – Overview, Market Size and Growth (Value-Wise: 2011 – 2016e), Blood Gas & Electrolyte Reagents – Overview, Market Size and Growth (Value-Wise: 2011 – 2016e)
Slide 19: Molecular Diagnostics – Overview, Market Size and Growth (Value-Wise: 2011 – 2016e), Molecular Diagnostics Instruments Segmentation (Value-Wise: 2011)
Slide 20: Molecular Diagnostics Instruments – Overview, Market Size and Growth (Value-Wise: 2011 – 2016e), Molecular Diagnostics Reagents – Overview, Market Size and Growth (Value-Wise: 2011 – 2016e)
Slide 21: Urinalysis – Overview, Market Size and Growth (Value-Wise: 2011 – 2016e), Urinalysis Instruments Segmentation (Value-Wise: 2011)
Slide 22: Urinalysis Instruments – Overview, Market Size and Growth (Value-Wise: 2011 – 2016e), Urinalysis Reagents – Overview, Market Size and Growth (Value-Wise: 2011 – 2016e)
Slide 23: Coagulation Analysis – Overview, Market Size and Growth (Value-Wise: 2011 – 2016e), Coagulation Analysis Instruments Segmentation (Units Sold: 2011)
Slide 24: Coagulation Analysis Instruments – Overview, Market Size and Growth (Value-Wise: 2011 – 2016e), Coagulation Analysis Reagents – Overview, Market Size and Growth (Value-Wise: 2011 – 2016e)

Drivers & Challenges

Slide 25: Summary
Slide 26-32: Drivers
Slide 33-34: Challenges

Laws and Guidelines

Slide 35: Directives Laid Down by Regulatory Bodies in Europe
Slide 36: Directives Laid Down by U.S. FDA
Slide 37: Directives Laid Down by Indian Government
Slide 38: Association of Diagnostics Manufacturers of India (ADMI)

Trends

Slide 39: Summary
Slide 40: Automation
Slide 41: Remote Data Acquisition, Enzyme-Linked Fluorescence Assay (ELFA)
Slide 42: Chemiluminescence Immunoassay (CLIA), Capillary Electrophoreses (CE) Based CLIA
Slide 43: Electrochemiluminescence Immunoassay (ECLIA)
Slide 44: Direct Access Testing, Rapid Accurate Quantification at Point of Care

Competition

Slide 45: Market Competition – Porter’s Five Forces Analysis
Slide 46-51: Major Public Companies (Domestic)
Slide 52-65: Major Private Companies (Domestic)
Slide 66-89: Major Private Companies (Foreign)
Strategic Recommendation
Slide 90-91: Key Recommendations

Appendix

Slide 92: Appendix
Slide 93: Sources of Information

More new market research reports by the publisher can be found at Netscribes page.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Tanya Rezler
Visit website